• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Simris Group

0.13 SEK+25.60 %16.7, 17.29
Less than 1K followers

SIMRIS B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+25.60 %
+41.61 %
+46.07 %
+211.00 %
+203.74 %
-25.71 %
-50.29 %
-74.21 %
-97.66 %

Simris Group is a biotechnology company. The company is focused on research and development of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. Simris Group was founded in 2011 and is headquartered in Hammenhög.

Read more
Market cap
175.47M SEK
Turnover
136.66K SEK
Revenue
1.62M
EBIT %
-1,830.46 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.8
2026

Interim report Q2'26

11.11
2026

Interim report Q3'26

24.2
2027

Annual report '26

Regulatory press release15.07.2026, 09.30

SIMRIS GROUP AB APPOINTS ADC EXPERT PROFESSOR ANDREAS PAHL AS CHIEF EXECUTIVE OFFICER OF ITS SUBSIDIARY SIMRIS BIOLOGICS GMBH

Simris Group
Regulatory press release13.07.2026, 11.15

A holder of warrants in Simris Group AB (publ) has declared his intention to exercise 3.3 million warrants amounting to total proceeds of EUR 15,000

Simris Group
Regulatory press release06.07.2026, 17.31

Holders of warrants in Simris Group AB (publ) have declared their intention to exercise 220 million warrants amounting to total proceeds of MEUR 1

Simris Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release24.06.2026, 17.05

Bulletin from Simris Group AB’s annual general meeting

Simris Group
Regulatory press release21.05.2026, 17.35

Correction: Notice of the Annual General Meeting of Simris Group AB (publ)

Simris Group
Regulatory press release21.05.2026, 16.30

Notice of Extraordinary General Meeting of Simris Group AB (publ)

Simris Group
Regulatory press release13.05.2026, 08.00

SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2026

Simris Group
Press release12.05.2026, 13.00

Simris Group Advances Asset Divestment Process with Two Prospective Buyers

Simris Group
Regulatory press release15.04.2026, 15.30

SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2025

Simris Group
Press release19.03.2026, 14.00

Simris evaluating options to expand its ADC-payload development programme and prepare for the next funding round to accelerate its plans.

Simris Group
Press release11.03.2026, 11.20

Simis provides an update on the divestment of its assets in Hammenhög, Sweden

Simris Group
Regulatory press release28.02.2026, 08.00

SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2025

Simris Group
Regulatory press release19.01.2026, 16.30

Bulletin from Simris Group AB’s extraordinary general meeting

Simris Group
Press release19.01.2026, 14.00

Simris Group enters into Memorandum of Understanding regarding divestment of assets in Hammenhög

Simris Group
Regulatory press release16.12.2025, 21.32

Simris Group AB (publ) receives notice of conversion of convertible bonds

Simris Group
Regulatory press release16.12.2025, 20.45

Notice of extraordinary general meeting in Simris Group AB (publ)

Simris Group
Regulatory press release16.12.2025, 20.43

Simris Group AB resolves on directed issue of units, proposes that an extraordinary general meeting resolves on additional share issues and announces acceptance of premature conversion of convertible debentures

Simris Group
Regulatory press release28.11.2025, 16.51

Simris Group enters into bridge loan agreement

Simris Group
Regulatory press release12.11.2025, 08.00

SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2025

Simris Group
Regulatory press release10.11.2025, 08.30

Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO

Simris Group